Concepedia

Publication | Open Access

Fenofibrate and Heart Failure Outcomes in Patients With Type 2 Diabetes: Analysis From ACCORD

DOIFull Paper Access

38

Citations

36

References

2022

Year

João Pedro Ferreira, Francisco Vasques‐Nóvoa, Diana Ferrão, Francisca Saraiva, Inês Falcão‐Pires, João Sérgio Neves, Abhinav Sharma, Patrick Rossignol, Faı̈ez Zannad, Adelino Leite‐Moreira
Diabetes Care

Abstract

In patients with T2D treated with simvastatin, fenofibrate reduced the composite of HF hospitalizations or cardiovascular mortality, an effect that was seen predominantly in patients with standard background glucose-lowering therapy.

References

YearCitations

Page 1